نتایج جستجو برای: pediatric aml and prognosis

تعداد نتایج: 16873517  

Journal: :iranian journal of pediatric hematology and oncology 0
حسین ایت اللهی hossein ayatollahi cancer molecular pathology research center, faculty of medicine, mashhad university of medical sciences, mashhad, iran ملیحه هاشمی نژاد maliheh hasheminezhad hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) آرزو شجاعی arezoo shojaiee cancer molecular pathology research center, faculty of medicine, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) محمدهادی صادقیان mohammad hadi sadeghian 4. department of hematology and blood bank, cancer molecular pathology research center, faculty of medicine, mashhad uniسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) احسان یزدان دوست ehsan yazdandoust department of hematology and blood bank, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) مریم شیخی maryam sheikhi cancer molecular pathology research center, faculty of medicine, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) سپیده شاکری

background: acute myeloid leukemia (aml) is a malignant disorder involving blood cells, characterized by obstructed or distorted differentiation of hematopoietic stem cells. in cytogenetically normal aml (cn aml), molecular abnormalities in npm, flt3, cebpa, and baalc genes are observed. initially, high baalc (brain and acute leukemia cytoplasmic gene) expression was introduced in a study on am...

Afsane Bahrami, Hossein Ayatollahi, Maryam Sheikhi, Mohammad Alidadi, Mohammad hadi sadeghian, Sepideh Shakeri, Seyyede Fatemeh Shams,

Background: Acute myeloid leukemia (AML) is one of myeloid malignancies which the risk increases with age increment. It is categorized based on genetic aberrations. Some of these genetic disorders can determine minimal residual diseases (MRD) and prognosis of AML patients. Wilms tumor (WT1) over expression is found in AML patients. The aim of this study was to determine the frequency of WT1 ove...

Journal: :iranian journal of pediatric hematology and oncology 0
hossein ayatollahi department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univerسازمان های دیگر: cancer molecular pathology research center mohammad hadi sadeghian department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univerسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)سازمان های دیگر: cancer molecular pathology research center sepideh shakeri cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) seyyede fatemeh shams cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) maryam sheikhi cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) mohammad alidadi cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

increment. it is categorized based on genetic aberrations. some of these genetic disorders can determine minimal residual diseases (mrd) and prognosis of aml patients. wilms tumor (wt1) over expression is found in aml patients. the aim of this study was to determine the frequency of wt1 over expression in aml pediatric cases in north -east of iran. materials and methods: this retrospective stud...

Background:Brain and Acute Leukemia Cytoplasmic (BAALC) is a gene which its expression is confined to progenitor cells; therefore, no expression has been illustrated in mature cells of bone marrow or white blood cells (WBC).  In addition, high BAALC expression is associated with poor prognosis in Acute Myeloid Leukemia (AML) individuals and is considered as an important risk factor in Cyto...

Journal: :Blood 2004
Patrick Brown Soheil Meshinchi Mark Levis Todd A Alonzo Robert Gerbing Beverly Lange Robert Arceci Donald Small

Pediatric acute myelogenous leukemia (AML) has a poor prognosis, and novel therapies are needed. The FLT3 tyrosine kinase represents a promising target in pediatric AML. FLT3 is constitutively activated either by an internal tandem duplication (ITD) or by a point mutation (PM) in 17% to 24% of pediatric AML cases. Autocrine stimulation of wild-type (WT) FLT3 by coexpressed FLT3 ligand (FL) occu...

Journal: :Blood 2011
Iris H I M Hollink Marry M van den Heuvel-Eibrink Susan T C J M Arentsen-Peters Marta Pratcorona Saman Abbas Jenny E Kuipers Janneke F van Galen H Berna Beverloo Edwin Sonneveld Gert-Jan J L Kaspers Jan Trka Andre Baruchel Martin Zimmermann Ursula Creutzig Dirk Reinhardt Rob Pieters Peter J M Valk C Michel Zwaan

Translocations involving nucleoporin 98kD (NUP98) on chromosome 11p15 occur at relatively low frequency in acute myeloid leukemia (AML) but can be missed with routine karyotyping. In this study, high-resolution genome-wide copy number analyses revealed cryptic NUP98/NSD1 translocations in 3 of 92 cytogenetically normal (CN)-AML cases. To determine their exact frequency, we screened > 1000 well-...

2016
Xiufang Zhang Yan Gu Zhaohui Sun Meifen Wan

Dysregulation of miR-224 has been shown to be involved in cancer tumorigenesis and progression of several cancer types. However, its expression patterns in tumors are controversial. The aim of this study was to determine the expression and clinical significance of miR-224 in pediatric acute myeloid leukemia (AML). Expression levels of miR-224 in bone marrow mononuclear cells were detected by re...

Journal: :Blood 2013
Eva A Coenen C Michel Zwaan Dirk Reinhardt Christine J Harrison Oskar A Haas Valerie de Haas Vladimir Mihál Barbara De Moerloose Marta Jeison Jeffrey E Rubnitz Daisuke Tomizawa Donna Johnston Todd A Alonzo Henrik Hasle Anne Auvrignon Michael Dworzak Andrea Pession Vincent H J van der Velden John Swansbury Kit-fai Wong Kiminori Terui Sureyya Savasan Mark Winstanley Goda Vaitkeviciene Martin Zimmermann Rob Pieters Marry M van den Heuvel-Eibrink

In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of prognosis. Some recurrent cytogenetic abnormalities, such as t(8;16)(p11;p13), are so rare that collaborative studies are required to define their prognostic impact. We collected the clinical characteristics, morphology, and immunophenotypes of 62 pediatric AML patients with t(8;16)(p11;p13) from 18 co...

Journal: :Blood 2009
Brian V Balgobind Susana C Raimondi Jochen Harbott Martin Zimmermann Todd A Alonzo Anne Auvrignon H Berna Beverloo Myron Chang Ursula Creutzig Michael N Dworzak Erik Forestier Brenda Gibson Henrik Hasle Christine J Harrison Nyla A Heerema Gertjan J L Kaspers Anna Leszl Nathalia Litvinko Luca Lo Nigro Akira Morimoto Christine Perot Rob Pieters Dirk Reinhardt Jeffrey E Rubnitz Franklin O Smith Jan Stary Irina Stasevich Sabine Strehl Takashi Taga Daisuke Tomizawa David Webb Zuzana Zemanova C Michel Zwaan Marry M van den Heuvel-Eibrink

Translocations involving chromosome 11q23 frequently occur in pediatric acute myeloid leukemia (AML) and are associated with poor prognosis. In most cases, the MLL gene is involved, and more than 50 translocation partners have been described. Clinical outcome data of the 11q23-rearranged subgroups are scarce because most 11q23 series are too small for meaningful analysis of subgroups, although ...

Journal: :Blood 2003
Tomohito Yagi Akira Morimoto Mariko Eguchi Shigeyoshi Hibi Masahiro Sako Eiichi Ishii Shuki Mizutani Shinsaku Imashuku Misao Ohki Hitoshi Ichikawa

Most patients with acute myeloid leukemia (AML) enter complete remission (CR) after treatment with chemotherapy, but a large number of them experience relapse with resistant disease. To identify genes that are associated with their prognoses, we analyzed gene expression in 54 pediatric patients with AML using an oligonucleotide microarray that contained 12 566 probe sets. A supervised approach ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید